Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 8:00 AM ET

Date/Time Source News Release
12/27/2024 05:00 PM EST PR Newswire Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
11/25/2024 08:03 AM EST PR Newswire Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval
11/22/2024 09:00 AM EST PR Newswire Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split
11/18/2024 04:05 PM EST PR Newswire Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering
11/15/2024 01:30 PM EST PR Newswire Citius Pharmaceuticals Announces $3 Million Registered Direct Offering
11/11/2024 08:45 AM EST PR Newswire Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR(TM) in Cancer Patients with Recurrent Solid Tumors
09/05/2024 04:30 PM EDT PR Newswire Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
09/05/2024 08:30 AM EDT PR Newswire Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR(TM) (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
08/12/2024 05:28 PM EDT PR Newswire Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update
08/12/2024 04:22 PM EDT PR Newswire Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
Page

Additional News

As of January 5, 2025 • 8:00 AM ET

Date/Time Source News Release
12/30/2024 01:56 AM EST SeekingAlpha Citius Pharmaceuticals GAAP EPS of -$5.97
11/22/2024 09:14 AM EST SeekingAlpha Citius Pharmaceuticals announces 1-for-25 reverse stock split
11/15/2024 02:34 PM EST SeekingAlpha Citius Pharmaceuticals stock tumbles on $3M securities offering
11/11/2024 10:47 AM EST SeekingAlpha Citius Pharmaceuticals reports positive early stage results of cancer combo treatment
08/18/2024 08:03 AM EDT SeekingAlpha Earnings week ahead: Zoom, Lowe's, Target, Baidu, XPeng, Zim Integrated and more
08/13/2024 05:40 AM EDT US Earnings Reports Expected earnings - Citius Pharmaceuticals Inc.
08/13/2024 02:14 AM EDT SeekingAlpha Citius Pharmaceuticals GAAP EPS of -$0.06 misses by $0.01
08/09/2024 03:00 PM EDT SeekingAlpha Catalyst Watch: Eyes on Walmart earnings, the July CPI print, and 13F filings
08/08/2024 01:15 PM EDT SeekingAlpha Citius wins FDA nod for Lymphir in cutaneous T-cell lymphoma
07/18/2024 10:20 AM EDT InvestorIdeas.com Biotech/Pharma Stocks to Watch Citius Pharmaceuticals, Soligenix, Takeda, Pfizer
Page